ImmuPharma plc (LON:IMM – Get Free Report)’s share price was up 14.4% during trading on Monday . The company traded as high as GBX 3.90 ($0.05) and last traded at GBX 3.59 ($0.05). Approximately 3,398,434 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 13,390,035 shares. The stock had previously closed at GBX 3.14 ($0.04).
ImmuPharma Stock Down 9.0 %
The company has a market capitalization of £13.77 million, a PE ratio of -5.60 and a beta of 1.53. The company has a 50-day moving average price of GBX 3.89 and a two-hundred day moving average price of GBX 2.37.
ImmuPharma Company Profile
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Recommended Stories
- Five stocks we like better than ImmuPharma
- 5 Top Rated Dividend Stocks to Consider
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Must-Own Stocks to Build Wealth This Decade
- High Flyers: 3 Natural Gas Stocks for March 2022
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
